Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 436,500
+22,000 (5.31%)
May 21, 2026, 3:30 PM KST
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 5.26 trillion as of May 20, 2026. Its market cap has increased by 73.07% in one year.
Market Cap
5.26T
Enterprise Value
5.66T
Revenue
1.55T
Ranking
n/a
PE Ratio
31.02
Stock Price
436,500.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 5.26T, an increase of 672.14%. That is a compound annual growth rate of 13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 5.26T | -8.30% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.19T |
| Celltrion Pharm | 2.19T |
| Hanall Biopharma | 2.09T |
| Daewoong Pharmaceutical | 1.53T |
| GC Biopharma | 1.49T |
| Chong Kun Dang Pharmaceutical | 1.05T |
| DongKook Pharmaceutical | 965.37B |
| Daewoong | 828.04B |